At the request of the Journal Editor and Publisher, the following articles have been retracted
Zhang T, Zhang L, Han D, Tursun K, Lu X. Circular RNA hsa_Circ_101141 as a competing endogenous RNA facilitates tumorigenesis of hepatocellular carcinoma by regulating miR-1297/ROCK1 pathway. Cell Transplantation. 2020;29. doi:10.1177/0963689720948016.
Du C, Wang Y, Zhang Y, Zhang J, Zhang L, Li J. LncRNA DLX6-AS1 contributes to epithelial–mesenchymal transition and cisplatin resistance in triple-negative breast cancer via modulating miR-199b-5p/paxillin axis. Cell Transplantation. 2020;29. doi:10.1177/0963689720929983.
Wan Q, Chen Q, Cai D, Zhao Y, Wu X. OTUB2 promotes homologous recombination repair through stimulating Rad51 expression in endometrial cancer. Cell Transplantation. 2020;29. doi:10.1177/0963689720931433.
Li W, Yang X, Shi C, Zhou Z. Hsa_circ_002178 promotes the growth and migration of breast cancer cells and maintains cancer stem-like cell properties through regulating miR-1258/KDM7A axis. Cell Transplantation. 2020;29:. doi:10.1177/0963689720960174.
Liu G, Guo W, Rao M, Qin J, Hu F, Li K. circRNA hsa_circ_104566 sponged miR-338-3p to promote hepatocellular carcinoma progression. Cell Transplantation. 2020;29. doi:10.1177/0963689720963948.
Li J, Yu Z, Zhu Q, Tao C, Xu Q. hsa_circ_102559 acts as the sponge of miR-130a-5p to promote hepatocellular carcinoma progression through regulation of ANXA2. Cell Transplantation. 2020;29. doi:10.1177/0963689720968748.
Li J, Yang Y, Xu D, Cao L. hsa_circ_0023409 accelerates gastric cancer cell growth and metastasis through regulating the IRS4/PI3K/AKT pathway. Cell Transplantation. 2021;30. doi:10.1177/0963689720975390.
Wang Y, Yin L. LINC00461 promoted endometrial carcinoma growth and migration by targeting MicroRNA-219-5p/cyclooxygenase-2 signaling axis. Cell Transplantation. 2021;30. doi:10.1177/0963689721989616.
Wu J, Wang X, Yuan X, et al. Kinesin family member C1 increases temozolomide resistance of glioblastoma through promoting DNA damage repair. Cell Transplantation. 2021;30. doi:10.1177/0963689721991466.
Hui Y, Yang Y, Li D, et al. LncRNA FEZF1-AS1 modulates cancer stem cell properties of human gastric cancer through miR-363-3p/HMGA2. Cell Transplantation. 2020;29. doi:10.1177/0963689720925059.
After an internal investigation, Sage has become aware that the submissions contain indicators of third-party involvement. Due to concerns around author contributions to the articles, as well as concerns around the integrity of the research process, Sage and the Journal Editor retract the articles.
The authors have been informed of this decision using the email addresses provided at submission.
References
1.
TorreLABrayFSiegelRLFerlayJLortet TieulentJJemalA. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
2.
FerlayJSoerjomataramIDikshitREserSMathersCRebeloMParkinDMFormanDBrayF. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
3.
BarZMNativLAssarafYLivneyY. Re-assembled casein micelles for oral delivery of chemotherapeutic combinations to overcome multidrug resistance in gastric cancer. J Mol Clin Med. 2018;1:52–61.
4.
RahmanRAsombangAWIbdahJA. Characteristics of gastric cancer in Asia. World J Gastroenterol. 2014;20(16):4483–4490.
5.
YangZWangJLiuSLiXMiaoLYangBZhangCHeJAiSGuanW. Defeating relapsed and refractory malignancies through a nano-enabled mitochondria-mediated respiratory inhibition and damage pathway. Biomaterials. 2020;229:119580.
6.
YangZWangJAiSSunJMaiXGuanW. Self-generating oxygen enhanced mitochondrion-targeted photodynamic therapy for tumor treatment with hypoxia scavenging. Theranostics. 2019;9(23):6809.
7.
YangZWangJLiuSSunFMiaoJXuETaoLWangYAiSGuanW. Tumor targeting W18O49 nanoparticles for dual modality imaging and guided heat shock response inhibited photothermal therapy in gastric cancer. Particle & Particle Systems Characterization. 2019;36(7):1900124.
8.
DuraesCAlmeidaGMSerucaROliveiraCCarneiroF. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?. Virchows Arch. 2014;464(3):367–378.
9.
JeongMHParkSYLeeSHSeoJYooJYParkSHKimMJLeeSJangSChoiHKLeeJE, et al.EPB41L5 mediates TGF--induced metastasis of gastric cancer. Clin Cancer Res. 2019; 25(12):3617–3629.
10.
HuangKKRamnarayananKZhuFSrivastavaSXuCTanALKLeeMTaySDasKXingMFatehullahA, et al.Genomic and Epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer. Cancer Cell. 2018;33(1):137–150.
11.
ClarkeMFDickJEDirksPBEavesCJJamiesonCHJonesDLVisvaderJWeissmanILWahlGM. Cancer stem cells perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66(19):9339–9344.
12.
SreepadmanabhMToleyBJ. Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics. Biotechnol Adv. 2018;36(4):1094–1110.
13.
ZhangXHuaRWangXHuangMGanLWuZZhangJWangHChengYLiJGuoW. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Oncotarget. 2016;7(9):9815–9831.
14.
SinghSR. Gastric cancer stem cells: a novel therapeutic target. Cancer Lett. 2013;338(1):110–119.
15.
RassouliFBMatinMMSaeinasabM. Cancer stem cells in human digestive tract malignancies. Tumour Biol. 2016;37(1):7–21.
16.
VisvaderJELindemanGJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10(6):717–728.
17.
LuLDaiZLuoQLvG. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma. Mol Med Rep. 2018;17(1):1947–1953.
18.
HanFWangCWangYZhangL. Long noncoding RNA ATB promotes osteosarcoma cell proliferation, migration and invasion by suppressing miR-200 s. Am J Cancer Res. 2017;7(4):770–783.
19.
ZhouCXuJLinJLinRChenKKongJShuiX. Long non-coding RNA FEZF1-AS1 promotes osteosarcoma progression by regulating miR-4443/NUPR1 axis [published online ahead of print February 22, 2018]. Oncol Res. 2018.
20.
BianZZhangJLiMFengYWangXZhangJYaoSJinGDuJHanWYinY, et al.LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling. Clin Cancer Res. 2018;24(19):4808–4819.
21.
YeHZhouQZhengSLiGLinQYeLWangYWeiLZhaoXLiWFuZ, et al.FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Cell Death Dis. 2018;9(2):34.
22.
LiuZZhaoPHanYLuS. lncRNA FEZF1-AS1 is associated with prognosis in lung adenocarcinoma and promotes cell proliferation, migration, and invasion. Oncol Res. 2018;27(1):39–45.
23.
LiuYWXiaRLuKXieMYangFSunMDeWWangCJiG. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Mol Cancer. 2017;16(1):39.
24.
HeRZhangFHShenN. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC). Biomed Pharmacother. 2017;95:331–338.
25.
PaciPColomboTFarinaL. Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. BMC Syst Biol. 2014;8:83.
26.
ZhouCXuJLinJLinRChenKKongJShuiX. Long noncoding RNA FEZF1-AS1 promotes osteosarcoma progression by regulating the miR-4443/NUPR1 axis. Oncology Res Feat Prec Cli Can Therapeutics. 2018;26(9):1335–1343.
27.
YeHZhouQZhengSLiGLinQYeLWangYWeiLZhaoXLiW. FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Cell Death Dis. 2018;9(2):34.
28.
SongBYanJLiuCZhouHZhengY. Tumor suppressor role of miR-363-3p in gastric cancer. Med Sci Monit. 2015;21:4074–4080.
29.
MotoyamaKInoueHNakamuraYUetakeHSugiharaKMoriM. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res. 2008;14(8):2334–2340.
30.
WangJLiangHGeHGuoXGuDYuanY. MicroRNA3633p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage. Mol Med Rep. 2019;19(2):935–942.
31.
LiWWangZZhaLKongDLiaoGLiH. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer. Oncol Rep. 2017;37(1):185–192.
32.
OrdituraMGaliziaGSforzaVGambardellaVFabozziALaterzaMMAndreozziFVentrigliaJSavastanoBMabiliaALietoE, et al.Treatment of gastric cancer. World J Gastroenterol. 2014;20(7):1635–1649.
33.
SchmittAMChangHY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.
34.
TianXZhuXYanTYuCShenCHongJChenHFangJY. Differentially expressed lncRNAs in gastric cancer patients: a potential biomarker for gastric cancer prognosis. J Cancer. 2017;8(13):2575–2586.
35.
WangJSunJWangJSongYGaoPShiJChenPWangZ. Long noncoding RNAs in gastric cancer: functions and clinical applications. Onco Targets Ther. 2016;9:681–697.
36.
GuYChenTLiGYuXLuYWangHTengL. LncRNAs: emerging biomarkers in gastric cancer. Future Oncol. 2015;11(17):2427–2441.
37.
ChenJFWuPXiaRYangJHuoXYGuDYTangCJDeWYangF. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer. 2018;17(1):6.
38.
SunMNieFWangYZhangZHouJHeDXieMXuLDeWWangZWangJ. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res. 2016;76(21):6299–6310.
39.
WeiGHWangX. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(17):3850–3856.
40.
WuXZhangPZhuHLiSChenXShiL. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway. Biomed Pharmacother. 2017;96:1103–1108.
41.
ReyaTMorrisonSJClarkeMFWeissmanIL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–111.
42.
ChenSZhuJWangFGuanZGeYYangXCaiJ. LncRNAs and their role in cancer stem cells. Oncotarget. 2017;8(66):110685–110692.
43.
HeWLiangBWangCLiSZhaoYHuangQLiuZYaoZWuQLiaoWZhangS, et al.MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. Oncogene. 2019.
44.
SongHXuYShiLXuTFanRCaoMXuWSongJ. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability. Biomed Pharmacother. 2018;108:338–346.
45.
WakamatsuYSakamotoNOoHZNaitoYUraokaNAnamiKSentaniKOueNYasuiW. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int. 2012;62(2):112–119.
46.
KatsunoYEhataSYashiroMYanagiharaKHirakawaKMiyazonoK. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-beta. J Pathol. 2012;228(3):391–404.
47.
JiangYHeYLiHLiHNZhangLHuWSunYMChenFLJinXM. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer. Gastric Cancer. 2012;15(4):440–450.
48.
ChenXLChenXZWangYGHeDLuZHLiuKZhangWHWangWLiCCXueLZhaoLY, et al.Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study. Oncotarget. 2016;7(38):62049–62069.
49.
YongXTangBXiaoYFXieRQinYLuoGHuCJDongHYangSM. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/beta-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett. 2016;374(2):292–303.
50.
Bekaii SaabTEl RayesB. Identifying and targeting cancer stem cells in the treatment of gastric cancer. Cancer. 2017;123(8):1303–1312.
51.
ZhengJZhaoSHeXZhengZBaiWDuanYChengSWangJLiuXZhangG. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2016;480(4):508–514.
52.
De CraeneBBerxG. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13(2):97–110.
53.
ChenFTianYPangEJWangYLiL. MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. Cancer Gene Ther. 2015.
54.
SaitoTKurashigeJNambaraSKomatsuHHirataHUedaMSakimuraSUchiRTakanoYShindenYIguchiT, et al.A long non-coding RNA activated by transforming growth factor-beta is an independent prognostic marker of gastric cancer. Ann Surg Oncol. 2015;22(Suppl 3):S915–S922.
55.
ZhaoYGuoQChenJHuJWangSSunY. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep. 2014;31(1):358–364.
56.
ZhaoJLiuYZhangWZhouZWuJCuiPZhangYHuangG. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle. 2015;14(19):3112–3123.
57.
XuZYYuQMDuYAYangLTDongRZHuangLYuPFChengXD. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013;9(6):587–597.
58.
LoPKWolfsonBZhouQ. Cancer stem cells and early stage basal-like breast cancer. World J Obstet Gynecol. 2016;5(2):150–161.
59.
ChenZLiuXHuZWangYLiuMLiuXLiHJiRGuoQZhouY. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol Lett. 2015;10(1):329–336.
